Related references
Note: Only part of the references are listed.Growth Hormone Resistance Exacerbates Cholestasis-Induced Murine Liver Fibrosis
Patricia Stiedl et al.
HEPATOLOGY (2015)
New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond
Ulrich Beuers et al.
JOURNAL OF HEPATOLOGY (2015)
Expression of Nestin in Remodelling of α-Naphthylisothiocyanate-induced Acute Bile Duct Injury in Rats
H. M. Golbar et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2014)
G-Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5) Agonists Reduce the Production of Proinflammatory Cytokines and Stabilize the Alternative Macrophage Phenotype
Klemens Hoegenauer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease
Rachel H. McMahan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Proteomic profiling in Lipocalin 2 deficient mice under normal and inflammatory conditions
Kirsten Labbus et al.
JOURNAL OF PROTEOMICS (2013)
Regulatory T cells control the CD8 adaptive immune response at the time of ductal obstruction in experimental biliary atresia
Celine S. Lages et al.
HEPATOLOGY (2012)
Immunophenotypic Alterations in Resident Immune Cells and Myocardial Fibrosis in the Aging Rhesus Macaque (Macaca mulatta) Heart
Sheila C. Macri et al.
TOXICOLOGIC PATHOLOGY (2012)
TGR5 potentiates GLP-1 secretion in response to anionic exchange resins
Taoufiq Harach et al.
SCIENTIFIC REPORTS (2012)
Combination of Retinoic Acid and Ursodeoxycholic Acid Attenuates Liver Injury in Bile Duct-Ligated Rats and Human Hepatic Cells
Hongwei He et al.
HEPATOLOGY (2011)
New Insights into Autoimmune Cholangitis through Animal Models
Michael Trauner et al.
DIGESTIVE DISEASES (2010)
Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches
Gideon M. Hirschfield et al.
GASTROENTEROLOGY (2010)
Genome-Wide Association Analysis in Primary Sclerosing Cholangitis
Tom H. Karlsen et al.
GASTROENTEROLOGY (2010)
The Binary HCO3- Umbrella: A Unifying Hypothesis on Pathogenetic and Therapeutic Aspects of Fibrosing Cholangiopathies
Ulrich Beuers et al.
HEPATOLOGY (2010)
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2010)
TopHat: discovering splice junctions with RNA-Seq
Cole Trapnell et al.
BIOINFORMATICS (2009)
Liver diseases related to MDR3 (ABCB4) gene deficiency
Emmanuel Gonzales et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Fibrogenesis in Pediatric Cholestatic Liver Disease: Role of Taurocholate and Hepatocyte-Derived Monocyte Chemotaxis Protein-1 in Hepatic Stellate Cell Recruitment
Grant A. Ramm et al.
HEPATOLOGY (2009)
Improved analysis of bile acids in tissues and intestinal contents of rats using LC/ESI-MS
Masahito Hagio et al.
JOURNAL OF LIPID RESEARCH (2009)
ToppGene Suite for gene list enrichment analysis and candidate gene prioritization
Jing Chen et al.
NUCLEIC ACIDS RESEARCH (2009)
Cholangiocyte anion exchange and biliary bicarbonate excretion
Jesus M. Banales et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice
P Fickert et al.
GASTROENTEROLOGY (2006)
Bile duct proliferation associated with bile salt-induced hypercholeresis in Mdr2 P-glycoprotein-deficient mice
CV Hulzebos et al.
LIVER INTERNATIONAL (2005)
Regurgitation of bile acids from leaky sclerosing cholangitis in Mdr2 (Abcb4) bile ducts causes knockout mice
P Fickert et al.
GASTROENTEROLOGY (2004)
Spontaneous cholecysto- and hepatolithiasis in Mdr2(-/-) mice: A model for low phospholipid-associated cholelithiasis
F Lammert et al.
HEPATOLOGY (2004)
Monitoring hepatic cholesterol 7α-hydroxylase activity by assay of the stable bile acid intermediate 7α-hydroxy-4-cholesten-3-one in peripheral blood
C Gälman et al.
JOURNAL OF LIPID RESEARCH (2003)
Effects of bile acids on biliary epithelial cells:: Proliferation, cytotoxicity, and cytokine secretion
T Lamireau et al.
LIFE SCIENCES (2003)
SC-435, an ileal apical sodium co-dependent bile acid transporter (ASBT) inhibitor lowers plasma cholesterol and reduces atherosclerosis in guinea pigs
KL West et al.
ATHEROSCLEROSIS (2003)
1-[4-[4[(4R,5R)-3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]butyl]-4-aza-1-azoniabicyclo[2.2.2]octane methanesulfonate (SC-435), an ileal apical sodium-codependent bile acid transporter inhibitor alters hepatic cholesterol metabolism and lowers plasma low-density lipoprotein-cholesterol concentrations in guinea pigs
KL West et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition
B Yerushalmi et al.
HEPATOLOGY (2001)
Share Paper
